Impact of random outliers in auto-segmented targets on radiotherapy treatment plans for glioblastoma
Open Access
- 22 October 2022
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 17 (1) , 1-18
Abstract
To save time and have more consistent contours, fully automatic segmentation of targets and organs at risk (OAR) is a valuable asset in radiotherapy. Though current deep learning (DL) based models are on par with manual contouring, they are not perfect and typical errors, as false positives, occur frequently and unpredictably. While it is possible to solve this for OARs, it is far from straightforward for target structures. In order to tackle this problem, in this study, we analyzed the occurrence and the possible dose effects of automated delineation outliers. First, a set of controlled experiments on synthetically generated outliers on the CT of a glioblastoma (GBM) patient was performed. We analyzed the dosimetric impact on outliers with different location, shape, absolute size and relative size to the main target, resulting in 61 simulated scenarios. Second, multiple segmentation models where trained on a U-Net network based on 80 training sets consisting of GBM cases with annotated gross tumor volume (GTV) and edema structures. On 20 test cases, 5 different trained models and a majority voting method were used to predict the GTV and edema. The amount of outliers on the predictions were determined, as well as their size and distance from the actual target. We found that plans containing outliers result in an increased dose to healthy brain tissue. The extent of the dose effect is dependent on the relative size, location and the distance to the main targets and involved OARs. Generally, the larger the absolute outlier volume and the distance to the target the higher the potential dose effect. For 120 predicted GTV and edema structures, we found 1887 outliers. After construction of the planning treatment volume (PTV), 137 outliers remained with a mean distance to the target of 38.5 ± 5.0 mm and a mean size of 1010.8 ± 95.6 mm3. We also found that majority voting of DL results is capable to reduce outliers. This study shows that there is a severe risk of false positive outliers in current DL predictions of target structures. Additionally, these errors will have an evident detrimental impact on the dose and therefore could affect treatment outcome.Keywords
This publication has 52 references indexed in Scilit:
- The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)IEEE Transactions on Medical Imaging, 2015
- Dosimetric and geometric evaluation of the use of deformable image registration in adaptive intensity-modulated radiotherapy for head-and-neck cancerJournal of Radiation Research, 2014
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2014
- Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition caseRadiation Oncology, 2013
- Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed systemActa Oncologica, 2013
- Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boostRadiation Oncology, 2013
- Atlas-Based Segmentation Improves Consistency and Decreases Time Required for Contouring Postoperative Endometrial Cancer Nodal VolumesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Emphasizing Conformal Avoidance Versus Target Definition for IMRT Planning in Head-and-Neck CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- A Radiation Oncologist's Guide to Contouring the HippocampusAmerican Journal of Clinical Oncology, 2009
- Variations in inter-observer contouring and its impact on dosimetric and radiobiological parameters for intensity-modulated radiotherapy planning in treatment of localised prostate cancerJournal of Radiotherapy in Practice, 2008